Qiong Fu, MD (she/her/hers)

Renji Hospital
Shanghai, Shanghai, China

Attending physician

Presentation(s):

• 1179: Efficacy and Safety of Ruxolitinib in Adult Patients With Refractory Connective Tissue Disease-Associated Macrophage Activation Syndrome

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 2465: CD19/BCMA Dual-Targeting FasTCAR-T Cells GC012F (AZD0120) in patients with refractory Systemic Lupus Erythematosusm: an open-label, single-center Phase I study

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 2672: Safety and efficacy of Upadacitinib in melanoma differentiation-associated gene 5-positive dermatomyositis with interstitial lung disease: a single-centre, retrospective, propensity score-matched cohort study

  Wednesday, October 29, 2025
  12:15 PM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose